Comparative Evaluation of Post Obturation Pain After Root Canal Treatment Using Tricalcium Silicate vs Resin-Based Sealers
A Comparative Evaluation of Post Obturation Pain After Root Canal Treatment Using Tricalcium Silicate Versus Resin-based Sealers in Cases With Symptomatic Irreversible Pulpitis
1 other identifier
interventional
118
1 country
1
Brief Summary
This is a randomized controlled trial comparing the mean and standard deviation of postobturation pain using two different sealers: a tricalcium silicate-based sealer (CeraSeal) and a resin-based sealer (Endoplus) in patients with symptomatic irreversible pulpitis undergoing root canal treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Feb 2026
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
February 5, 2026
January 1, 2026
6 months
December 7, 2025
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain after root canal treatment assessed using a Visual Analogue Scale (VAS)
Postoperative pain will be recorded using a 10-centimeter Visual Analogue Scale (VAS). On this scale, 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores correspond to greater pain intensity, meaning more pain. Patients will self-report their pain level at each time point (24 hours, 72 hours, and 7 days). This measure will be used to compare postoperative pain between patients treated with Endoplus resin-based sealer and CeraSeal bioceramic sealer.
24 hours, 72 hours and 7 days
Study Arms (2)
Tricalcium silicate based sealer (Bio ceramic)
ACTIVE COMPARATORCeraSeal bioceramic sealer will be used for obturation with matched bioceramic cones and a heated plugger (System B).
Resin based sealer
EXPERIMENTALEndoplus resin-based sealer will be used for obturation with single-cone gutta-percha and a heated plugger (System B)
Interventions
Endoplus (resin-based sealer) - assigned to Group 1
Ceraseal (bioceramic sealer) - assigned to Group 2
Eligibility Criteria
You may qualify if:
- Patients of age group 18 to 60 years
- Healthy patients with ASA class 1 and 2
- Patients of both genders
- Teeth diagnosed as symptomatic irreversible pulpitis
- Single as well as multirooted teeth
You may not qualify if:
- Teeth with calcified or previously treated canals
- Immunocompromised or mentally handicapped patients
- Pregnant or lactating mothers
- Teeth with periodontal probing depths of 5 mm or more
- Cracked or un restorable teeth
- Teeth where root canal instrumentation could not reach within 2 mm of the radiographic apex
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Armed Force Institute of Dentistry
Rawalpindi, Punjab Province, 46000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Pooja Kumari, Principal Investigator and Resident, Operative Dentistry and Endodontics
Study Record Dates
First Submitted
December 7, 2025
First Posted
February 5, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2027
Last Updated
February 5, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared with other researchers because this trial involves a small patient sample, and the data contains identifiable clinical information that cannot be fully anonymized without compromising patient confidentiality. The dataset is intended solely for analysis within the approved research protocol, as permitted by the Institutional Ethics Review Committee. Therefore, IPD sharing is not planned.